NATX Plasmids, for: DNA Vaccines, Gene Therapeutics, Viral Vectors andBiophamacueticals

DNA Vaccines: Rapid Development and Rapid Deployment
Providing vaccines in a pandemic timeframe

Site Map

NTC Homepage

Vectors
XServices
XPricing
XManuals

Hyper-Taq™ DNA Polymerase

DNA Vaccines Vectors
XRapidVACC™

Proteins:
XRecombinant Proteins
XpVEX™
XFluorescent Proteins

Plasmids
XSmall Scale Plasmid DNA
XSmall Scale C of A
XLarge Scale Plasmid DNA
XLarge Scale C of A
XPlasmid DNA Order Form

XE. coli Cell Paste
X
DNA Fermentation Process
XHyperGRO™ Process
XHyperGRO™ Licensing
XHyperGRO™ Prices

Process Development
XProcess Development Basics
XProcess Licensing

Research and Development
XTechnologies
XPublications
XPatents
XPress Releases
XPartnering Opportunities

Corporate Profile
XManagement Team
XBoard of Directors
XInvestor Information

Contact Us
XScientific Meetings
XEmployment

NTC's new (2010), rapidly deployable set of DNA vaccination tools can be readily adapted to any antigens in a two-week, "precision cloning" turnaround service, providing vaccines in a pandemic timeframe.

To date, DNA vaccines have shown great promise, and effectiveness in a limited number of animal models. However, they typically lacked the 'quantum leap' in efficacy that is needed for large animal and human use. NTC has now improved the DNA backbone architecture, including:

Reduced genome (only essential sequences: increases potency, decreases recombination potential)
Trafficking (DNA to the nucleus, protein to selected presentation pathways)
Optimized expression via transcriptional and translational enhancement and a synthetic intron
Antibiotic free (meets regulatory demands)
Selected co-stimulators (activates antigen presentation, prevents tolerization)
Highest yield in the fermentor (increases purity, cost effectiveness)
Vector Selection Flowchart
Selection
Transgene Targeting
HTLV-I R transient expression enhancer
VA1 transient expression enhancer
SV40-PAS-BH increased plasmid yield  backbone
RIG-I activating backbone
Vector
Kan Secreted; GPI anchored; Proteosome; Endosome; or  Native
No
No
No
No
pDNAVACCUltra
Sucrose
Secreted; or Native
Yes
No
No
No
NTC8382
NTC8385
Sucrose Secreted; or Native
Yes
Yes
No
No
NTC8382-VA1
NTC8385-VA1
Kan Secreted; or Native
Yes
No
*Yes
No
NTC7482
NTC7485
Kan Secreted; or Native
Yes
Yes
*Yes
Yes
NTC7482-eRNA41H
NTC7485-eRNA41H
Sucrose Secreted; or Native
Yes
No
*Yes
No
NTC8482
NTC8485
Sucrose Secreted; or Native
Yes
Yes
*Yes
Yes
NTC8482-eRNA41H
NTC8485-eRNA41H
Sucrose Secreted; or Native
Yes
Yes
*Yes
No
NTC8682
NTC8685

*Save 20% off large scale production cost with NTC’s high-yield, SV40-PAS-BH vectors!
(for a limited time)



Rapid-VACC™ is streamlined process whereby we provide you with custom-finished DNA vaccine vectors, sequence-validated and ready for animal testing, in record time - a new weapon in the arsenal against infectious diseases, bioterrorism and cancer therapy. Call for more information.

• Rapid assembly of antigens and adjuvant genes into pDNAVaccUltra™ vectors

• Rapid screening of candidate vaccine vectors using Multi-Mode presentation

• Rapid optimization and improvement

Rapid development of protein boost with pVex™ antigen expression system

High throughput DNA vaccine plasmid generation is a quick, cost effective method for generating intracellular targeted DNA vaccines. In today's world, emerging infectious diseases (like SARS, anthrax, smallpox, West Nile, monkeypox and bird flu ) and bioterrorist threats can appear on our doorstep and spread like wildfire. Now it is possible to create technological weapons against these threats in weeks, instead of months or years.


RapidVACC™ high throughput DNA vaccine plasmid generation is a quick, cost effective process for targeted DNA vaccine vectors. We provide multiple plasmids, each with different destinations, for your gene of interest. Each plasmid utilizes NTC’s proprietary pDNA-VACC-Ultra™ plasmid backbone, optimized for both high level expression of target antigens, appropriate co-stimulatory elements, and for harmonization with FDA points to consider on plasmid DNA vaccines. Immunization with the series of plasmids allows you to rapidly determine the optimal MHC presentation of your protein.

NTC will PCR amplify and clone your gene in pDNAVACC-Ultra™ vaccine expression vector A series using your template and sequence data, sequence insert and ship 4 cell lines to you for in as little as three weeks!

You will receive cell lines* containing your gene in NTC' s pDNAVACC-ultra™.

A1: secreted
A2: membrane anchored
A3: intracellular processing targeted
A4: native


Contact NTC, Toll free: 1-(888) WIZ-BANG

Plasmids, Recombinant Proteins, DNA Vaccines, Viral Vectors, Therapeutic Genes, Fermentation Technology for Gene Therapy and Biotechnology
NTC's free resource "Site" for the biotechnology industry,
including Databases and Sequences Analysis Tool
s



WWW http://www.natx.com